Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease

Journal of Clinical Neuroscience

Volumn 21, Issue 3, 2014, Pages 451-455

  Kirbas, Aynur ^a   Kirbas, Serkan ^a   Cure, Medine Cumhur ^a   Tufekci, Ahmet ^a  

^a RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

Author keywords

Arylesterase; Oxidative stress index; Paraoxonase; Parkinson's disease; Total anti oxidant status; Total oxidant status

Indexed keywords

ARYLESTERASE; OXIDATIVE STRESS INDEX; PARAOXONASE; PARKINSON'S DISEASE; TOTAL ANTI-OXIDANT STATUS; TOTAL OXIDANT STATUS;

ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 84895089375     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.04.025     Document Type: Article

References (28)

1. K. Ikeda, Y. Nakamura, and T. Kiyozuka et al. Serological profiles of urata, paraoxonase-1, ferritin and lipid in parkinson's diseases changes linked to diseases progression Neurodegener Dis 8 2011 252 258
2. R.L. Miller, M. James-Kracke, and G.Y. Sun et al. Oxidative and inflammatory pathways in parkinson's disease Neurochem Res 34 2009 55 65
3. Shukla V, Mishra SK, Pant HC. Oxidative Stress in Neurodegeneration. Advances in Pharmacological Sciences 2011;2011:572634.
4. R. Betarbet, T.B. Sherer, and J.T. Greenamyre Ubiquitin-proteasome system and Parkinson's diseases Exp Neurol 191 2005 S17 27
5. K.P. Loh, S.H. Huang, and R. De Silva et al. Oxidative stress: apoptosis in neuronal injury Curr Alzheimer Res 3 2006 327 337
6. M. Serafini, and D. Del Rio Understanding the association between dietary anti-oxidants redox status and disease: is the total antioxidant capacity the right tool? Redox Rep 9 2004 145 152
7. E. Barbieri, and P. Sestili Reactive oxygen species in skeletal muscle signaling J Signal Transduct 2012 2012 982794
8. M.P. Mattson Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders Antioxid Redox Signal 8 2006 1997 2006
9. O. Erel A new automated colorimetric method for measuring total oxidant status Clin Biochem 38 2005 1103 1111
10. O. Erel A novel automated method to measure total anti-oxidant response against potent free radical reactions Clin Biochem 37 2004 112 119
11. A. Carmine, S. Buervenich, and O. Sydow et al. Further evidence for an association of the Paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease Mov Disord 17 2002 764 766
12. V.P. Androutsopoulos, K. Kanavouras, and A.M. Tsatsakis Role of paraoxonase 1(PON 1) in organophosphate metabolism: implications in neurodegenerative diseases Toxicol Appl Pharmacol 256 2012 418 424
13. Z.G. She, H.Z. Chen, and Y. Yan et al. The humanparaoxonase gene cluster as a target in the treatment of atherosclerosis Antioxid Redox Signal 16 2012 597 632
14. L.P. Précourt, D. Amre, and M.C. Denis et al. The three-gene paraoxonase family: physiologic roles, actions and regulatIon Atherosclerosis 214 2011 20 36
15. S.N. Akhmedova, A.K. Yakimovsky, and E.I. Schwartz Paraoxonase 1 Met-Leu54 polymorphism is associated with Parkinson's disease J Neurol Sci 184 2001 179 182
16. J. Wang, and Z. Liu No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population Mov Disord 15 2000 1265 1267
17. S.E. Daniel, and A.J. Lees Parkinson's Disease Society Brain Bank, London: overview and research J Neural Transm. 39 suppl 1993 165 172
18. K.N. Gan, A. Smolen, and H.V. Eckerson et al. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities Drug Metab Dispos 19 1991 100 106
19. I. Seres, G. Paragh, and E. Deschene et al. Study of factors influencing the decreased HDL associated PON1 activity with aging Exp Gerontol 39 2004 59 66
20. M.C. Taylor, D.G. Le Couteur, and G.D. Mellick et al. Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population J Neural Transm 107 2000 979 983
21. M.I. Mackness, S. Arrol, and P.N. Durrington Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein FEBS Lett 286 1991 152 154
22. J. Berbecki, K. Mitosek-Szewczyk, and J. Kurzepa et al. Processes of free radical lipid peroxidation with a particular regard to the role of paraoxonase -1 in the pathogenesis of multiple sclerosis Wiad Lek 64 2011 31 36
23. G. Hu, R. Antikainen, and P. Jousilahti et al. Total cholesterol and the risk of Parkinson disease Neurology 70 2008 1972 1979
24. L.M. De Lau, P.J. Koudstaal, and A. Hofman et al. Serum cholesterol levels and the risk of Parkinson's disease Am J Epidemiol 164 2006 998 1002
25. A.D. Manthripragada, S. Costello, and M.G. Cockburn et al. Paraoxonase 1, agricultural organophosphate exposure, and Parkinson's diseases Epidemiology 21 2010 87 94
26. C.S. Fong, C.W. Cheng, and R.M. Wu Pesticides exposure and genetic polymorphisms of paraoxonase in the susceptibility Parkinson's disease Acta Neurol Taiwan 14 2005 55 60
27. C.E. Furlong, S.M. Suzuki, and R.C. Stevens et al. Human PON1, a biomarker of risk of diseases and exposure Chem Biol Interact 187 2010 355 361
28. T.S. Wingo, A. Rosen, and D.J. Cutler et al. Paraoxonase 1 polymorphisms in Alzheimer's diseases, Parkinson's disease, and AD-PD spectrum diseases Neurobiol Aging 33 2012 204.e13-5